11 results
management table comparison decisionaid a1c agonists antidiabetic costs diabetic diagnosis dpp4 eudka euglycemic glp1 indications inpatient ketoacidosis mellitus metformin oral
Diabetes Medications Summary Table Insulin Lifestyle modifications Metformin Sulfonylureas GLP-1 receptor agonists - ↓ major adverse CV events TZDs DPP-4 inhibitors SGLT2 inhibitors -
Diabetes Medications ... SGLT2 inhibitors ... - ↓ major adverse ... comparison #management #endocrinology ... #dm2
Profiles of Antidiabetic Medications - AACE 2018 #Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
of Antidiabetic Medications ... #Profiles #SideEffects ... DecisionAid #Orals #DM2 ... #Diabetes #Endocrinology ... #Pharmacology #
Diabetes Medication Choice -Diabetes Medication Choice decision aid cards provide information on medications commonly used to treat
Diabetes Medication ... only metformin, SGLT-i ... #Type2 #DM2 #PatientInfo ... #Selection #SideEffects ... Reduction #Costs #Pharmacology
SGLT2 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors ... - Pharmacology ... #Inhibitors #Pharmacology ... #Summary #DM2 # ... diabetes #endocrinology
SGLT2 Inhibitors SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
SGLT2 Inhibitors ... SGLT2 inhibitors ... #Inhibitors #Pharmacology ... #Medications #DM2 ... #Diabetes #Endocrinology
Metformin - First Line Treatment for Diabetes Type 2 • Start with initial dose of 500 mg
Treatment for Diabetes ... gastrointestinal (GI) adverse ... form and consider using ... #Titration #Pharmacology ... #Diabetes #DM2
Diabetes Mellitus Type 2 Inpatient Medication Guide Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Type 2 Inpatient Medication ... receptor agonist, SGLT2i ... #Mellitus #DM2 ... #pharmacology # ... comparison #table #endocrinology
Euglycemic Diabetic Ketoacidosis (EuDKA) SGLT2 Inhibitors Increasing Indications Significant Adverse Drug Effects Definition of EuDKA • Metabolic acidosis with pH
Ketoacidosis (EuDKA) SGLT2 ... Inhibitors Increasing ... Indications Significant ... Adverse Drug Effects ... diagnosis #management #endocrinology
DPP4 Inhibitors - Normal and Renal Dosing Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Normal and Renal Dosing ... #Renal #Dosing ... #Pharmacology #Management ... #Diabetes #DM2 ... #Endocrinology
GLP-1 Agonists Adlyxin (Lixisenatide) Daily Bydureon (Exenatide ER) Weekly Ozempic (Semaglutide) Weekly Trulicity (Dulaglutide) Weekly Victoza (Liraglutide) Daily
commonly used medications ... to treat Type 2 Diabetes ... GLP1 #Agonists #Pharmacology ... #Dosing #Diabetes ... #DM2 #Endocrinology
No results found for "Diabetes Pharmacology medications algorithm sideeffects dm2 adverse dosing endocrinology inhibitors sglt2"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Diabetes #Pharmacology #medications #algorithm #sideeffects #dm2 #adverse #dosing #endocrinology #inhibitors #sglt2